Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds

Kyle LaHucik

Senior Reporter

Curie.Bio, a Cambridge, MA-based biotech accelerator that aims to “free the founders,” has raised a $380 million fund mainly to support nascent startups that graduate …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry

Exclusive: J&J folds cardiovascular and metabolic drug unit

FDA approves Dupixent in COPD, opening ‘next chapter’ for Sanofi and Regeneron’s bestseller

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

FDA approves Bristol Myers and Karuna's schizophrenia drug, in milestone for psychiatry

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

Alex­is Borisy and Zach Wein­berg's Curie.Bio se­cures $380M to sup­port port­fo­lio's Se­ries A rounds

Senior Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds